Cardiovascular benefit from RA biologics

Current biologic use but not previous biologic use decreases the risk of cardiovascular events in patients with inflammatory arthritis, Australian figures show. The findings come from a study of data from more than 4,000 patients on the Australian Rheumatology Association Database (ARAD) with a diagnosis of rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis. Follow-up was for ...

Already a member?

Login to keep reading.

© 2021 the limbic